Group One Trading
RKDA icon

Group One Trading’s Arcadia Biosciences RKDA Stock Holding History

Group One Trading’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-50
Closed -$2K – 8125
2022
Q2 		$2K Sell
50
-3
-6% -$138 ﹤0.01% 7429
2022
Q1 		$3K Buy
53
+13
+33% +$620 ﹤0.01% 7646
2021
Q4 		$2K Sell
40
-140
-78% -$9.13K ﹤0.01% 7901
2021
Q3 		$15K Buy
180
+12
+7% +$1.13K ﹤0.01% 7322
2021
Q2 		$20K Sell
168
-85
-34% -$9.27K ﹤0.01% 7193
2021
Q1 		$28K Buy
+253
New +$31K ﹤0.01% 6594

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Group One Trading's RKDA Position: Q1 2026 in Review

Group One Trading held its Arcadia Biosciences (RKDA) position steady in Q1 2026 at 18 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #7459.

Group One Trading first reported a position in RKDA in Q1 2022 and has held it in 17 quarters since. The position peaked at $23K in Q1 2022. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Group One Trading held 18 shares of Arcadia Biosciences worth $25 as of Q1 2026.
  • Group One Trading left its Arcadia Biosciences share count unchanged in Q1 2026.
  • Arcadia Biosciences made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7459 holding.
  • Group One Trading first reported a position in Arcadia Biosciences in Q1 2022 and has held it in 17 quarters since.
  • Group One Trading's Arcadia Biosciences position peaked at $23K in Q1 2022.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.